Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Wajeeh Khan

Nuvalent Stock Hits All-Time High Following GSK's Buyout Offer

Nuvalent (NUVL) stock ripped higher on June 9 after GSK (GSK) announced a $10.6 billion all-cash deal to acquire the Nasdaq-listed precision oncology company.

The British pharmaceutical behemoth will commence a tender offer at $124 per share, representing a massive 40% premium on NUVL’s previous close.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.